HOME >> MEDICINE >> NEWS
Triple-drug therapy promising against African HIV subtype

Triple-drug antiretroviral regimens that are widely used in the United States and Europe against one HIV-1 subtype appear to be effective in South African patients infected with a different HIV-1 subtype who also have tuberculosis (TB) or Kaposi's sarcoma (KS), according to a study published in the Feb.1 issue of The Journal of Infectious Diseases, now available online. The South African subtype, known as subtype C, is rapidly spreading in developing countries, where TB and KS are major factors in AIDS morbidity and mortality. Since the triple-drug regimens have markedly reduced the morbidity and mortality associated with the subtype that predominates in developed countries (subtype B), the implication is that they may be similarly effective against the C subtype in developing countries as well.

The authors, Edana Cassol and coworkers in Durban, South Africa and the United States, studied 49 patients with previously untreated HIV-1 infection, 21 of whom had pulmonary TB and 28 of whom had KS. Patients in the TB group first received standard TB treatment, then an antiretroviral combination that has been successfully used to treat HIV-1 subtype B infections in patients with active TB--didanosine, lamivudine, and efavirenz, all purchased from Western manufacturers. KS patients received a combination of generic stavudine, lamivudine, and nevirapine, all manufactured in India; some also received cancer chemotherapy. Responses to antiretroviral therapy were measured in part by plasma HIV RNA levels and the number of peripheral blood CD4 cells, which help to orchestrate immune responses.

After three months, 94 percent of the TB group and 80 percent of the Kaposi group had undetectable HIV RNA levels--rates equivalent to or better than those in studies involving Western patients infected with the B subtype. The decrease occurred rapidly during the first 7 days of treatment, then gradually until virus was undetectable--a pattern reported in Western B subtype-
'"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
28-Dec-2004


Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... ... October 10, 2019 , ... In attendance ... was excited to hear the significant results of an independent study presented by ... Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate and ...
(Date:10/8/2019)... British Columbia (PRWEB) , ... October 08, 2019 , ... ... the current and future state of aging and wellness in the nation? That question ... Council on Active Aging Conference, Leadership Summit and Expo. The event will take place ...
(Date:10/8/2019)... ... October 08, 2019 , ... In Vitro Sciences (IVS), a ... Care (AFC), an advanced reproductive services (RE) facility operating in the greater Phoenix ... services to expectant families throughout Arizona and the greater Southwest. , This partnership ...
(Date:10/8/2019)... ... 2019 , ... Cognosante has been awarded a contract to ... Care Referrals and Authorizations program. The new task order will allow Cognosante ... an enterprise-wide system used by community care staff to generate referrals and authorizations ...
(Date:10/8/2019)... ... October 08, 2019 , ... As a ... Meiqing Shi, associate professor with the University of Maryland Department of Veterinary Medicine, ... in Nature Communications, Shi and his lab have discovered a new pathway by ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... October 11, 2019 , ... ... has announced plans for its 2019 'W' Health Month. The plans are aimed ... by bridging the knowledge gap, providing access to health checks and encouraging healthy ...
(Date:10/11/2019)... , ... October 11, 2019 , ... Based on data ... a 9 percent increase in deceased organ donors over 2018. Through August 31, 7,786 ... Transplantation Network (OPTN) national database . At this pace, the Association of Organ ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once again ... reproductive medicine, with six abstracts accepted for poster presentations at the ASRM 2019 ... 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in the ...
Breaking Medicine Technology:
Cached News: